Dr Anne Poljak | Meet Our Researcher Series
For Dr Anne Poljak, finding the mechanisms underlying cognitive decline and neurodegenerative diseases such as dementia and identifying disease biomarkers are fundamental n
For Dr Anne Poljak, finding the mechanisms underlying cognitive decline and neurodegenerative diseases such as dementia and identifying disease biomarkers are fundamental n
CHeBA’s Genetics & Epigenomics Group is primarily concerned with identifying factors defining healthy cognitive function, as well as physical and mental wellbeing.
A PhD Candidate at CHeBA, Heidi Foo has taken a holistic approach to investigating determinants of healthy brain ageing by investigating the effect of genetic and environme
Dr Adith Mohan’s transition from clinician to clinician-researcher stems from his interest in applying the principles of neuroscience to his clinical practice as a neuropsy
One of the most dynamic functions of Dr Browning’s role as Study Coordinator of the Sydney Centenarian Study is meeting with a diverse array of individuals, with undeniably
The field of healthy brain ageing is broad and across researchers there is the common goal of ground-breaking outcomes to change the landscape of cognitive decline research
Josie Bigland is working toward becoming a Clinical Psychologist, with a personal goal of giving back to the community; specifically, families en
Dr Rebecca Koncz’s research explores the pathophysiological mechanisms of Alzheimer’s disease, particularly amyloid accumulation, as a hallmark feature of the disease.
The participants of CHeBA’s Sydney Centenarian Study have quite literally a century’s worth of knowledge and possibly the most diversified life experience of us all.
As our understanding of brain health expands rapidly, more and more individuals are becoming extremely health conscious.